BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17521732)

  • 1. C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission.
    Takada E; Okahira S; Sasai M; Funami K; Seya T; Matsumoto M
    Mol Immunol; 2007 Jul; 44(15):3633-40. PubMed ID: 17521732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway.
    Sasai M; Tatematsu M; Oshiumi H; Funami K; Matsumoto M; Hatakeyama S; Seya T
    Mol Immunol; 2010 Mar; 47(6):1283-91. PubMed ID: 20047764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling.
    Funami K; Matsumoto M; Oshiumi H; Akazawa T; Yamamoto A; Seya T
    Int Immunol; 2004 Aug; 16(8):1143-54. PubMed ID: 15226270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
    Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
    Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal binding site in the human toll-like receptor 3 ectodomain.
    Watanabe T; Tokisue T; Tsujita T; Matsumoto M; Seya T; Nishikawa S; Hasegawa T; Fukuda K
    Nucleic Acids Symp Ser (Oxf); 2007; (51):405-6. PubMed ID: 18029758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing.
    Seya T; Matsumoto M; Ebihara T; Oshiumi H
    Immunol Rev; 2009 Jan; 227(1):44-53. PubMed ID: 19120474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.
    Su X; Li S; Meng M; Qian W; Xie W; Chen D; Zhai Z; Shu HB
    Eur J Immunol; 2006 Jan; 36(1):199-206. PubMed ID: 16323247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomerized TICAM-1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF-kappaB activation and type I IFN induction.
    Takaki H; Oshiumi H; Sasai M; Kawanishi T; Matsumoto M; Seya T
    Eur J Immunol; 2009 Dec; 39(12):3469-76. PubMed ID: 19795416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
    Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
    Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.
    Chiron D; Pellat-Deceunynck C; Amiot M; Bataille R; Jego G
    J Immunol; 2009 Apr; 182(7):4471-8. PubMed ID: 19299748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of RNA aptamers against human Toll-like receptor 3 ectodomain.
    Watanabe T; Ito K; Matsumoto M; Seya T; Nishikawa S; Hasegawa T; Fukuda K
    Nucleic Acids Symp Ser (Oxf); 2006; (50):251-2. PubMed ID: 17150912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction.
    Shingai M; Azuma M; Ebihara T; Sasai M; Funami K; Ayata M; Ogura H; Tsutsumi H; Matsumoto M; Seya T
    Int Immunol; 2008 Sep; 20(9):1169-80. PubMed ID: 18611945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular structure of the TLR3 extracellular domain.
    Bell JK; Botos I; Hall PR; Askins J; Shiloach J; Davies DR; Segal DM
    J Endotoxin Res; 2006; 12(6):375-8. PubMed ID: 17254392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the interaction between human TLR3 ectodomain and nucleic acids.
    Fukuda K; Tsujita T; Matsumoto M; Seya T; Sakiyama H; Nishikawa F; Nishikawa S; Hasegawa T
    Nucleic Acids Symp Ser (Oxf); 2006; (50):249-50. PubMed ID: 17150911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights of rohu TLR3, its binding site analysis with fish reovirus dsRNA, poly I:C and zebrafish TRIF.
    Sahoo BR; Basu M; Swain B; Maharana J; Dikhit MR; Jayasankar P; Samanta M
    Int J Biol Macromol; 2012 Nov; 51(4):531-43. PubMed ID: 22705475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway.
    Jiang Q; Wei H; Tian Z
    BMC Cancer; 2008 Jan; 8():12. PubMed ID: 18199340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR3: interferon induction by double-stranded RNA including poly(I:C).
    Matsumoto M; Seya T
    Adv Drug Deliv Rev; 2008 Apr; 60(7):805-12. PubMed ID: 18262679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells.
    Nakada E; Walley KR; Nakada T; Hu Y; von Dadelszen P; Boyd JH
    Placenta; 2009 Sep; 30(9):774-9. PubMed ID: 19631980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down modulation of human TLR3 function by a monoclonal antibody.
    Duffy KE; Lamb RJ; San Mateo LR; Jordan JL; Canziani G; Brigham-Burke M; Korteweg J; Cunningham M; Beck HS; Carton J; Giles-Komar J; Duchala C; Sarisky RT; Mbow ML
    Cell Immunol; 2007 Aug; 248(2):103-14. PubMed ID: 18048020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation.
    Peter ME; Kubarenko AV; Weber AN; Dalpke AH
    J Immunol; 2009 Jun; 182(12):7690-7. PubMed ID: 19494293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.